Prelude Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-647
| Closed | -$212K | – | 1198 |
|
|
2025
Q4 | $212K | Buy |
+647
| New | +$205K | 0.02% | 1024 |
|
|
2025
Q1 | – | Sell |
-1,070
| Closed | -$279K | – | 1172 |
|
|
2024
Q4 | $279K | Sell |
1,070
-3,007
| -74% | -$892K | 0.02% | 831 |
|
|
2024
Q3 | $1.31M | Sell |
4,077
-598
| -13% | -$196K | 0.08% | 314 |
|
|
2024
Q2 | $1.46M | Sell |
4,675
-3,665
| -44% | -$1.08M | 0.1% | 243 |
|
|
2024
Q1 | $2.37M | Buy |
+8,340
| New | +$2.44M | 0.12% | 202 |
|
|
2022
Q3 | – | Sell |
-1,230
| Closed | -$299K | – | 1557 |
|
|
2022
Q2 | $299K | Buy |
+1,230
| New | +$301K | 0.01% | 1061 |
|
|
2021
Q1 | – | Sell |
-2,744
| Closed | -$631K | – | 1511 |
|
|
2020
Q4 | $631K | Buy |
+2,744
| New | +$633K | 0.02% | 634 |
|
|
2020
Q1 | – | Sell |
-119
| Closed | -$29K | – | 1403 |
|
|
2019
Q4 | $29K | Sell |
119
-163
| -58% | -$35.9K | ﹤0.01% | 1504 |
|
|
2019
Q3 | $55K | Buy |
+282
| New | +$54.1K | ﹤0.01% | 1132 |
|
|
2017
Q1 | – | Sell |
-4,358
| Closed | -$637K | – | 1482 |
|
|
2016
Q4 | $637K | Buy |
4,358
+2,633
| +153% | +$396K | 0.08% | 277 |
|
|
2016
Q3 | $288K | Sell |
1,725
-319
| -16% | -$53.9K | 0.03% | 446 |
|
|
2016
Q2 | $311K | Sell |
2,044
-415
| -17% | -$64.5K | 0.04% | 383 |
|
|
2016
Q1 | $369K | Sell |
2,459
-4,012
| -62% | -$596K | 0.05% | 357 |
|
|
2015
Q4 | $1.05M | Buy |
6,471
+1,191
| +23% | +$187K | 0.16% | 148 |
|
|
2015
Q3 | $730K | Buy |
5,280
+237
| +5% | +$37.4K | 0.11% | 222 |
|
|
2015
Q2 | $774K | Buy |
5,043
+1,313
| +35% | +$210K | 0.11% | 218 |
|
|
2015
Q1 | $596K | Sell |
3,730
-1,773
| -32% | -$279K | 0.08% | 286 |
|
|
2014
Q4 | $877K | Buy |
5,503
+2,224
| +68% | +$347K | 0.13% | 178 |
|
|
2014
Q3 | $461K | Buy |
3,279
+735
| +29% | +$96K | 0.06% | 396 |
|
|
2014
Q2 | $301K | Sell |
2,544
-4,970
| -66% | -$575K | 0.04% | 563 |
|
|
2014
Q1 | $927K | Buy |
7,514
+1,069
| +17% | +$130K | 0.12% | 204 |
|
|
2013
Q4 | $735K | Buy |
6,445
+3,950
| +158% | +$449K | 0.12% | 241 |
|
|
2013
Q3 | $279K | Sell |
2,495
-3,643
| -59% | -$395K | 0.05% | 438 |
|
|
2013
Q2 | $606K | Buy |
+6,138
| New | +$637K | 0.13% | 203 |
|
Other funds holding AMGN
VCM
VPM
Prelude Capital Management's AMGN Position: Q1 2026 in Review
Prelude Capital Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 647 shares — an estimated $212K sold.
Prelude Capital Management first reported a position in AMGN in Q2 2013 and held it in 24 quarters. The position peaked at $2.37M in Q1 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Prelude Capital Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
- Prelude Capital Management sold 647 Amgen shares in Q1 2026, an estimated $212K.
- Prelude Capital Management first reported a position in Amgen in Q2 2013 and held it in 24 quarters.
- Prelude Capital Management's Amgen position peaked at $2.37M in Q1 2024.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.